SCHEMBL4710139

SCHEMBL4710139

CC1(C)CN(C(=O)NCCN2CCOCC2)C=C(C(=O)O)c2[nH]c3ccccc3c21

nearest known ligand 0.58

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
NR1H4 Q96RI1 20/20 0.58
KCNH2 Q12809 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4708589 0.95 NR1H4 (0.56) NR1H4KCNH2
SCHEMBL4522477 0.88 NR1H4 (0.74) NR1H4KCNH2
SCHEMBL1964410 0.84 NR1H4 (0.80) NR1H4KCNH2
SCHEMBL4526019 0.84 NR1H4 (0.72) NR1H4KCNH2
SCHEMBL4711292 0.82 NR1H4 (0.50) NR1H4
SCHEMBL1969196 0.82 NR1H4 (0.79) NR1H4KCNH2
SCHEMBL4522479 0.81 NR1H4 (0.47) NR1H4KCNH2
SCHEMBL4760883 0.80 NR1H4 (0.80) NR1H4KCNH2
SCHEMBL1968461 0.80 NR1H4 (0.82) NR1H4KCNH2
SCHEMBL1965284 0.80 NR1H4 (0.82) NR1H4KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1963331-A1 AZEPINOINDOLE DERIVATIVES AS PHARMACEUTICAL AGENTS Exelixis, Inc. (US) 2008-09-03 EP claimed
WO-2007070796-A1 AZEPINOINDOLE DERIVATIVES AS PHARMACEUTICAL AGENTS EXELIXIS, INC. (US) 2007-06-21 WO claimed
EP-1963331-A1 AZEPINOINDOLE DERIVATIVES AS PHARMACEUTICAL AGENTS Exelixis, Inc. (US) 2008-09-03 EP disclosed
WO-2007070796-A1 AZEPINOINDOLE DERIVATIVES AS PHARMACEUTICAL AGENTS EXELIXIS, INC. (US) 2007-06-21 WO disclosed